79.7%
oncolytic virus therapyglioblastomaAd5-D24-PEPvIIIPEPvIIIgliomaPD-L1 inhibitor
…nd 1 (PD-L1) expression in the tumor microenvironment following oncolytic virus therapy may limit its therapeutic effectiveness. To address this, we fi…
1articles mentioning treatments
1treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: oncolytic virus therapy ×
oncolytic virus therapy
This treatment is selected. Its supporting articles are shown below.